CHRISTABEL OKOYE: Open Payments
NPI 1265049969 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 12 payments from 7 companies in 2025. Trend: 2023 $96 · 2024 $733 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $93 |
| E.R. Squibb & Sons, L.L.C. | 1 | $57 |
| Novo Nordisk Inc | 2 | $36 |
| SANOFI-AVENTIS U.S. LLC | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: QULIPTA, COBENFY, Ozempic, TZIELD, UBRELVY, COSENTYX, PYRUKYND, EVENITY.
Industry payments across GA — which companies pay providers there.
